desloratadine actavis
actavis group ptc ehf - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - behandling af allergisk rhinitis og urticaria.
desloratadine ratiopharm
ratiopharm gmbh - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - desloratadine ratiopharm is indicated in adults for the relief of symptoms associated with:allergic rhinitischronic idiopathic urticaria as initially diagnosed by a physician.
desloratadine teva
teva b.v - desloratadin - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - desloratadine teva er indiceret til lindring af symptomer forbundet med allergisk rhinitis;urticaria.
neoclarityn
n.v. organon - desloratadin - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistaminer til systemisk brug, - neoclarityn er indiceret til lindring af symptomer forbundet med allergisk rhinitisurticaria.
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - antitrombotiske midler - xarelto, co-gives sammen med acetylsalicylsyre (asa) alene eller sammen med asa plus clopidogrel eller ticlopidin, der er indiceret til forebyggelse af atherothrombotic hændelser hos voksne patienter efter en akut koronar syndrom (acs) med forhøjet kardiale biomarkører. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. forebyggelse af venøs tromboembolisme (vte) hos voksne patienter, der gennemgår valgfri hofte- eller knæskifteoperation. behandling af dyb venøs trombose (dvt) og lungeemboli (pe), og forebyggelse af recidiverende dvt og pe i voksne. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
deslor 5 mg filmovertrukne tabletter
rowex ltd. - desloratadin - filmovertrukne tabletter - 5 mg
deslor 0,5 mg/ml oral opløsning
rowex ltd. - desloratadin - oral opløsning - 0,5 mg/ml
desloratadin "actavis ptc" 0,5 mg/ml oral opløsning
actavis group ptc ehf. - desloratadin - oral opløsning - 0,5 mg/ml
desloratadin al 5 mg filmovertrukne tabletter
aliud pharma gmbh & co. kg - desloratadin - filmovertrukne tabletter - 5 mg
desloratadin "cipla" 5 mg filmovertrukne tabletter
cipla europe nv - desloratadin - filmovertrukne tabletter - 5 mg